Clinical Trials Sponsored by Brendan Lee

Total 1975 results

Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union

Femoral Shaft Fracture | Bone Marrow

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet Rich Plasma for Knee Osteoarthritis

Osteo Arthritis Knee | Platelet-rich Plasma

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet-rich Plasma for Chronic Lateral Ankle Instability

Platelet-rich Plasma | Ankle Instability

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet-rich Plasma for Meniscus Repair

Knee Injuries | Platelet-Rich Plasma | Meniscus Disorder

Taiwan
H. Lee Moffitt Cancer Center and Research Institute
Pediatric Cancer Foundation

Completed

Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
Roche Pharma AG

Terminated

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

Adenocarcinoma | Colon Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
BTG International Inc.

Completed

Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma

Cholangiocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
BTG International Inc.

Completed

Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets

Pancreatic Cancer | Liver Cancer

United States
Jeong Gu Lee
Astellas Pharma Korea, Inc.

Completed

A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence

Stress Urinary Incontinence | Urgency Urinary Incontinence

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute
Novartis; Genentech, Inc.

Completed

Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

Head and Neck Cancer | Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Terminated

Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation

Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Completed

Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts

Myelodysplastic Syndromes

United States
ProCertus BioPharm, Inc
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

Radiodermatitis

United States
H. Lee Moffitt Cancer Center and Research Institute
Kite, A Gilead Company

Recruiting

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Acute Lymphoblastic Leukemia | B-Cell Lymphoblastic Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Outreach Core Activities

Cancer Education | Spanish Language Cancer Education

United States, Puerto Rico
H. Lee Moffitt Cancer Center and Research Institute
Pancreatic Cancer Action Network

Recruiting

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Ocular Melanoma | Uveal Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Evaluating Stress Management Among Allogeneic HCT Caregivers

Stress | Burden

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Clinical Trials Outreach & Education

Knowledge, Attitudes, Practice

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Recruiting

Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers

Smoking Cessation

United States
H. Lee Moffitt Cancer Center and Research Institute
Regeneron Pharmaceuticals; Sanofi-Synthelabo

Recruiting

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

United States
Kil Yeon Lee
National Research Foundation of Korea

Recruiting

Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE) (MIRACLE)

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Cachexia | Biliary Tract Cancer | Precachexia

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Merkel Cell Carcinoma | Neuroendocrine Carcinoma of the Skin | Trabecular Carcinoma of the Skin

United States
H. Lee Moffitt Cancer Center and Research Institute
National Pediatric Cancer Foundation

Recruiting

Evolutionary Therapy for Rhabdomyosarcoma

Rhabdomyosarcoma

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Active, not recruiting

Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome

Head and Neck Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Active, not recruiting

Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative

Colorectal Cancer

United States
AC Camargo Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Completed

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET)

Neuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor

United States, Brazil
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Active, not recruiting

Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health (CARES-REACH)

Colorectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Smoking Cessation for Cervical Cancer Survivors

Smoking Cessation | Cervical Cancer | Tobacco Use

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis Pharmaceuticals; RECORDATI GROUP

Completed

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

Neuroendocrine Tumors | Carcinoid Tumors

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Natural History of HPV Infection in Men: The HIM Study

Human Papillomavirus

United States
H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Completed

Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks (IACCT)

Colorectal Cancer | Colorectal Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
University of South Florida

Completed

Physical Activity for Advanced Stage Cancer Patients

Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Smoking Relapse-Prevention Intervention for Cancer Patients

Smoking Cessation

United States
H. Lee Moffitt Cancer Center and Research Institute
Gateway for Cancer Research

Completed

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease (Ustekinumab)

Graft vs. Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

Prostatic Hyperplasia

United States
Sei Won Lee
Korea Centers for Disease Control & Prevention

Unknown

Impact of Particulate Matter in Chronic Obstructive Pulmonary Disease Patients

COPD
CHEOL WHAN LEE, M.D., Ph.D
CardioVascular Research Foundation, Korea

Terminated

EARly Prevention of aTHeroma Progression (EARTH)

Coronary Arteriosclerosis

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
University of South Florida

Completed

Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer

Ovarian Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

R115777 in Treating Patients With Advanced Bladder Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Terminated

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia

Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal Cancer

Colorectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Melanoma (Skin)

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Withdrawn

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Unknown

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

Unspecified Adult Solid Tumor, Protocol Specific
Jonathan Troy Grennan
Canadian Institutes of Health Research (CIHR)

Recruiting

Doxycycline Intervention for Bacterial STI ChemoprOphylaxis (DISCO)

Bacterial Sexually Transmitted Diseases

Canada
Association Nationale pour les Traitements A Domicile...

Recruiting

Robot-assisted and Connected 6-minute Walk Test (TM6)

Respiratory Insufficiency

France

Clinical Trials Sponsored by Brendan Lee

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations